IceCure Medical Ltd ICCM
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 2.79M | 3.27M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 2.79M | 3.27M | |
| Cost of Revenue | -- | -- | 1.79M | 1.87M | |
| Gross Profit | -- | -- | 1.00M | 1.40M | |
| SG&A Expenses | -- | -- | 9.93M | 10.29M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 18.65M | 18.98M | |
| Operating Income | -- | -- | -15.86M | -15.70M | |
| Income Before Tax | -- | -- | -15.58M | -15.30M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -15.58 | -15.30 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -15.58M | -15.30M | |
| EBIT | -- | -- | -15.86M | -15.70M | |
| EBITDA | -- | -- | -15.54M | -15.37M | |
| EPS Basic | -- | -- | -8.39 | -0.29 | |
| Normalized Basic EPS | -- | -- | -2.57 | -0.09 | |
| EPS Diluted | -- | -- | -8.39 | -0.29 | |
| Normalized Diluted EPS | -- | -- | -2.57 | -0.09 | |
| Average Basic Shares Outstanding | -- | -- | 7.47M | 214.41M | |
| Average Diluted Shares Outstanding | -- | -- | 7.47M | 214.41M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |